Abbott Laboratories vs. Maravai LifeSciences Holdings, Inc. Class A Common Stock
ABT
Abbott Laboratories
$104.89 +0.20%
VS MRVIMaravai LifeSciences Holdings, Inc. Class A Common Stock
$6.79 -3.96%
Abbott Laboratories and Maravai LifeSciences Holdings, Inc. Class A Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ABT | MRVI | |
|---|---|---|
| Market Cap | $181.50 billion | $1.01 billion |
ABT leads on 1 of 1 size & scale factors.
Dividend
| ABT | MRVI | |
|---|---|---|
| Dividend Yield | 2.40% | — |
ABT and MRVI split the dividend factors evenly.
Risk & Sentiment
| ABT | MRVI | |
|---|---|---|
| Short Interest | 0.57% | 0.42% |
MRVI leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, MRVI overview, MRVI financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.